Gene Editing, “Cultural Harms,” and Oversight Mechanisms
By Erik Parens,
Bioethics Forum
| 05. 04. 2017
Is it reasonable to hope that concerns about “cultural harms” can be integrated into oversight mechanisms for technologies like gene editing? That question was raised anew for me by the recent National Academy of Sciences report on human genome editing and at a recent conference at Harvard on the international governance of genome editing technologies. I’m somewhat disheartened to be thinking that the answer might be no.
Before explaining how I ended up in what is, for me, a disheartening place, I should clarify what I take the authors of the NAS report to mean by the term “cultural harms.” First, they were not emphasizing that concerns about emerging technologies can vary from culture to culture or from nation to nation. They weren’t talking about how, say, Samoans and Singaporeans hold different values, and about how such differences might make international governance difficult.
They were using “cultural harms” in contradistinction to what we might call “physical harms.” When we worry about physical harms we worry that a technology is going to fail at achieving some near-term purpose we take to...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...